1. Molecular Biology of Osteosarcoma.
    Anna M Czarnecka et al, 2020, Cancers (Basel) CrossRef
  2. Osteocytes and Bone Metastasis
    Manuel A. Riquelme et al, 2020, Front. Endocrinol. CrossRef
  3. Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma
    N. E. Kushlinskii et al, 2020, Mol Biol CrossRef
  4. Gene signatures with predictive and prognostic survival values in human osteosarcoma
    Zhongpeng Qiu et al, 2021 CrossRef
  5. Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies
    Richa Rathore et al, 2021, JCM CrossRef
  6. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20
    Yuan Gao et al, 2021, Aging CrossRef
  7. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein
    Lu Ding et al, 2021, Aging CrossRef
  8. Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
    Kirstine Sandal Nørregaard et al, 2021, IJMS CrossRef
  9. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma
    Jun Wang et al, 2021, J Orthop Surg Res CrossRef
  10. Overexpression of Long Non-Coding RNA MIR22HG Represses Proliferation and Enhances Apoptosis via miR-629-5p/TET3 Axis in Osteosarcoma Cells
    Haoliang Zhao et al, 2021, J. Microbiol. Biotechnol. CrossRef
  11. LIM Kinases in Osteosarcoma Development
    Régis Brion et al, 2021, Cells CrossRef
  12. The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival
    Chao Wang et al, 2022, Sci Rep CrossRef
  13. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
    Xinying Zhou et al, 2022, Front. Cell Dev. Biol. CrossRef
  14. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis
    Xiujin Chen et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  15. Orchestrated Tumor Apoptosis (Cu2+) and Bone Tissue Calcification (Ca2+) by Hierarchical Copper/Calcium-ensembled Bioactive Silica for Osteosarcoma Therapy
    Ya-Hui Han et al, 2022, Chemical Engineering Journal CrossRef
  16. Advances in the role of miRNAs in the occurrence and development of osteosarcoma
    Guanyu Zhang et al, 2020 CrossRef
  17. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
    Negin Soghli et al, 2022, Biochemical Pharmacology CrossRef
  18. Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy
    Liliya Kazantseva et al, 2022, Molecules CrossRef
  19. High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
    Xiaohong Jiang et al, 2023, Front. Oncol. CrossRef
  20. The regulatory effects of p53 on the typical and atypical ferroptosis in the pathogenesis of osteosarcoma: A systematic review
    Linfeng Wang et al, 2023, Front. Genet. CrossRef
  21. Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma
    Hrituraj Dey et al, 2023, Front. Med. CrossRef
  22. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development
    Sara Ferreira Pires et al, 2023, Mol Genet Genomics CrossRef
  23. Osteosarcoma multicéntrico sincrónico en paciente pediátrico de 15 años. Reporte de un caso
    Gabriel J David Tarud et al, 2023, Pediatria. CrossRef
  24. Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells
    Xiaohui Luo et al, 2023, Gene CrossRef
  25. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment
    Abinaya Shanmugavadivu et al, 2024, Biomed. Mater. CrossRef
  26. Research Progress in Correlation between MTDH and Osteosarcoma
    宇航 魏, 2024, ACM CrossRef
  27. RNA-binding proteins in bone pathophysiology
    Paola Maroni et al, 2024, Front. Cell Dev. Biol. CrossRef
  28. Aurora-B: a novel biomarker in the invasion and metastasis of osteosarcoma
    Siping Long et al, 2024, Biomarkers in Medicine CrossRef
  29. Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
    Jordan C. O’Donoghue et al, 2024, Front. Immunol. CrossRef
  30. PD-1 interactome in osteosarcoma: identification of a novel PD-1/AXL interaction conserved between humans and dogs
    Katarzyna Dziubek et al, 2024, Cell Commun Signal CrossRef
  31. Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS
    Chaoyi Yin et al, 2025, Front. Pharmacol. CrossRef
  32. Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
    Lei Sun et al, 2025, Front. Immunol. CrossRef